2016 annual financial data
TG Therapeutics 2016 Revenue growth
Direct answer
Revenue growth was 0%.
Operating income was -78,969,128 USD and net income was -78,252,894 USD.
Operating cash flow was -61,591,330 USD.
Get free TG Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 152,381 USD
- Operating income
- -78,969,128 USD
- Net income
- -78,252,894 USD
- Operating cash flow
- -61,591,330 USD